NCT04221945 2026-02-20KEYNOTE-A18Merck Sharp & Dohme LLCPhase 3 Completed1,060 enrolled 30 charts 2 FDA
NCT03635567 2026-02-04KEYNOTE-826Merck Sharp & Dohme LLCPhase 3 Completed617 enrolled 29 charts 2 FDA